74 filings
Page 2 of 4
8-K
nkadn 2x98z
20 Oct 21
F-star Therapeutics Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics
9:01am
8-K
8h9n 4skqw8r6r6
17 Aug 21
Entry into a Material Definitive Agreement
4:02pm
8-K
oneuij 8592i
12 Aug 21
F-star Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
10:08am
8-K
znvta u1ch16
14 Jul 21
F-star Therapeutics Enters into Exclusive Licensing Agreement with AstraZeneca for Novel STING Inhibitors
5:21pm
8-K
flmtpvot77 t2om6k
4 Jun 21
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
eshinqyto h2lv96b
17 May 21
F-star Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
8:35am
8-K
ud63mppf
10 May 21
F-star Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
12:00am
8-K
4351u uk6vucfgs
6 May 21
Termination of a Material Definitive Agreement
4:33pm
8-K
kh5tohvgvtomgi
14 Apr 21
Other Events
12:00am
8-K
0qanjfkr24fn0gd
5 Apr 21
Next Generation Immunotherapies. Overcoming Cancer. Full-Year 2020 Financial Results and Corporate Update 29th March 2021
4:03pm
8-K
fw640nhz2
5 Apr 21
Changes in Registrant's Certifying Accountant
4:01pm
8-K
fe8l8eza0yp0
29 Mar 21
F-star Therapeutics Reports Full-Year 2020 Financial Results and Provides Corporate Update
8:15am
8-K/A
zp1d4zcv rz98wc8y
5 Feb 21
Other Events
4:49pm
8-K
i1c06c 4jxlg
4 Jan 21
F-star Therapeutics Announces First Patient Dosed in FS222 Phase 1 Clinical Trial
4:01pm
8-K
wbqhyo2bo9gd
4 Dec 20
F-star Therapeutics Announces First Patient Dosed in First-in-Class
11:55am
8-K
5i1ti
25 Nov 20
F-star Therapeutics Announces Clearance of
4:40pm
8-K
9drg 9o1qa
20 Nov 20
F-star Therapeutics Completes Combination with Spring Bank Pharmaceuticals
4:41pm
8-K
y563dr6
9 Nov 20
Spring Bank Pharmaceuticals Announces Special Dividend of Contingent Value Rights
8:01am
8-K
9675ib47
12 Aug 20
Regulation FD Disclosure
8:00am
8-K
9f08o
10 Aug 20
Spring Bank Pharmaceuticals Reports Second Quarter 2020 Financial and Operational Results
4:12pm